4/A

FORM 4/A SUBMISSION

Company: Lineage Cell Therapeutics, Inc.
Filed: February 2, 2004
Period of Report: January 21, 2004
Accession Number: 0001209191-04-006100

View Document ↗ View on SEC.gov ↗